Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights
06:46pm, Thursday, 16'th Oct 2025
Novavax (NVAX) reached $8.48 at the closing of the latest trading day, reflecting a -4.83% change compared to its last close.
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
01:08pm, Tuesday, 14'th Oct 2025
Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine.
Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps
06:09am, Tuesday, 14'th Oct 2025
Shah Capital has urged Novavax's board to pursue a sale of the biotech, citing a third consecutive year of poor roll-out of its COVID-19 shot, the hedge fund said on Tuesday.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Wednesday, 08'th Oct 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
GAITHERSBURG, Md. , Oct. 7, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the marketing authorization for its COVID-19 vaccine, Nuvaxovid® to Sanofi, in the European
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
06:46pm, Monday, 06'th Oct 2025
Novavax (NVAX) closed the most recent trading day at $9.08, moving 4.02% from the previous trading session.
Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider
06:46pm, Tuesday, 30'th Sep 2025
The latest trading day saw Novavax (NVAX) settling at $8.67, representing a +1.17% change from its previous close.
Novavax Announces Progress on Sanofi Agreement
09:01am, Tuesday, 30'th Sep 2025
GAITHERSBURG, Md. , Sept. 30, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced progress on its collaboration and license agreement (CLA) with Sanofi regarding Novavax's Matrix-M®
Here's Why Novavax (NVAX) is a Strong Momentum Stock
10:50am, Friday, 26'th Sep 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
10:00am, Thursday, 25'th Sep 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax (NVAX) Declines More Than Market: Some Information for Investors
06:46pm, Tuesday, 23'rd Sep 2025
Novavax (NVAX) concluded the recent trading session at $8.68, signifying a -2.2% move from its prior day's close.
Mizuho's Jared Holz: There's not much value left in vaccine stocks
11:40am, Friday, 19'th Sep 2025
Jared Holz, Mizuho healthcare senior strategist, joins CNBC's 'Squawk on the Street' to discuss outlooks on pharmaceuticals, what new government vaccine panel recommendations mean for the stocks, and
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
01:49pm, Thursday, 18'th Sep 2025
The reworked ACIP will make its debut Friday when the panelists weigh the suite of new Covid boosters from Pfizer, Moderna and Novavax.
Here's Why Novavax (NVAX) Fell More Than Broader Market
06:46pm, Wednesday, 17'th Sep 2025
Novavax (NVAX) closed at $8.39 in the latest trading session, marking a -1.99% move from the prior day.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 10'th Sep 2025
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
